Oppenheimer Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX)
Oppenheimer started coverage on shares of Quince Therapeutics (NASDAQ:QNCX – Free Report) in a report released on Monday, ...
Opthea (NASDAQ:OPT) Rating Lowered to Market Perform at Oppenheimer
Oppenheimer lowered shares of Opthea (NASDAQ:OPT – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, MarketBeat reports. A number of other ...